SIMULTEST CD3/ANTI-HLA-DR— 510(k) K924587

Substantially Equivalent

Becton Dickinson Immunocytometry Systems

FDA 510(k) clearance K924587 for SIMULTEST CD3/ANTI-HLA-DR, Substantially Equivalent on 1993-08-05. Applicant: Becton Dickinson Immunocytometry Systems. Device class: 2.

Clearance details

Applicant
Becton Dickinson Immunocytometry Systems
Product code
Code GKZ
Device class
Class 2
Regulation
21 CFR 864.5220
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Jose, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code GKZ

view all

More clearances from Becton Dickinson Immunocytometry Systems

view all

Adverse events under product code GKZ

product code GKZ
Malfunction
1,205
Total
1,205

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.